{
    "root": "308634ec-a951-6d67-e063-6294a90ace5b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Estradiol",
    "value": "20250317",
    "ingredients": [
        {
            "name": "ESTRADIOL",
            "code": "4TI98Z838E",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_23965"
        }
    ],
    "indications": {
        "text": "estradiol gel , 0.06 % estrogen indicated : treatment moderate severe vasomotor symptoms due menopause ( 1.1 ) treatment moderate severe symptoms vulvar vaginal atrophy due menopause ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "generally , estrogen prescribed postmenopausal woman uterus , consider addition progestogen reduce risk endometrial cancer . generally , woman without uterus need progestogen addition estrogen therapy . cases , however , hysterectomized women history endometriosis may need progestogen [ ( 5.2 , 5.14 ) ] . estrogen-alone , combination progestogen lowest effective dose shortest duration consistent treatment goals risks individual woman . reevaluate postmenopausal women periodically clinically appropriate determine treatment still necessary .",
        "doid_entities": [
            {
                "text": "endometrial cancer (DOID:1380)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1380"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            },
            {
                "text": "endometriosis (DOID:289)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_289"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "estradiol gel contraindicated women following conditions : \u2022 undiagnosed abnormal genital bleeding [ ( 5.2 ) ] \u2022 breast cancer history breast cancer [ ( 5.2 ) ] \u2022 estrogen-dependent neoplasia [ ( 5.2 ) ] \u2022 active dvt , pe , history conditions [ ( 5.1 ) ] \u2022 active arterial thromboembolic disease ( example , stroke myocardial infarction ) , history conditions [ ( 5.1 ) ] \u2022 known anaphylactic reaction , angioedema , hypersensitivity estradiol gel \u2022 hepatic impairment disease \u2022 protein c , protein , antithrombin deficiency , known thrombophilic disorders",
    "indications_original": "Estradiol gel, 0.06% is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ) Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause ( 1.2 )",
    "contraindications_original": "Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, consider addition of a progestogen to reduce the risk of endometrial cancer. Generally, a\u00a0 woman without a uterus does not need to use a progestogen in addition to her estrogen therapy. In some cases, however, hysterectomized women with a history of endometriosis may need a progestogen\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.2,\n  \n   5.14)]\n \n  .\n\n \n                  Use estrogen-alone, or in combination with a progestogen at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman.\u00a0Reevaluate postmenopausal women periodically as clinically appropriate to determine if treatment is still necessary.",
    "adverseReactions_original": "Estradiol gel is contraindicated in women with any of the following conditions:\n                  \u2022 Undiagnosed abnormal genital bleeding\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.2)]\n \n  \n                       \u2022\u00a0Breast cancer or a history of breast cancer\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.2)]\n \n  \n                       \u2022 Estrogen-dependent neoplasia\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.2)]\n \n  \n                       \u2022 Active DVT, PE, or history of these conditions\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.1)]\n \n  \n                       \u2022 Active arterial thromboembolic disease (for example, stroke\u00a0or MI), or a history of these conditions\n \n  [see\n  \n   Warnings and Precautions\u00a0(\n  \n   5.1)]\n \n  \n                       \u2022 Known anaphylactic reaction, angioedema, or hypersensitivity\u00a0to estradiol gel \n    \u2022\u00a0Hepatic impairment or disease \n    \u2022 Protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders",
    "drug": [
        {
            "name": "Estradiol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_23965"
        }
    ]
}